IBM opens drug discovery database to the NIH

12/13/2011 | Pharmaceutical Business Review Online · iHealthBeat

IBM will open its database of about 2.4 million chemical compounds to the NIH for research. AstraZeneca, Bristol-Myers Squibb, DuPont and Pfizer collaborated with IBM to compile the database based on millions of patent filings and journal abstracts published between 1976 and 2000.

View Full Article in:

Pharmaceutical Business Review Online · iHealthBeat

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN